RB

Rabindranath Barman

Active Director Director DIN 10115935
DIN 10115935 First appointment Apr 2023 Primary industry Biotechnology
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2023
Shareholding value •••• Premium profile

About Rabindranath Barman

Data last updated:

Rabindranath Barman is a Director at Nutri Pharma Vaccines Private Limited (since 2023). The company operates in Biotechnology. Nutri Pharma Vaccines Private Limited reported revenue of ₹25.69 Cr (FY 2025).

DIN 10115935
Primary Designation Director
Industry Biotechnology
First Appointment 16 Apr 2023
Oldest Company Age 3 yrs
Largest company Nutri Pharma Vaccines Private Limited · ₹25.69 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director16 Apr 20232023₹25.69 Cr (FY 2025)Active

Board colleagues of Rabindranath Barman

Directorship timeline

Open interactive timeline →
Nutri Pharma Vaccines Private Limited
Premium access

Shareholding and investment profile for Rabindranath Barman

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rabindranath Barman

Rabindranath Barman currently holds 1 directorship: Nutri Pharma Vaccines Private Limited (Director, since 16 Apr 2023, revenue ₹25.69 Cr (FY 2025)).

Rabindranath Barman was first appointed on 16 Apr 2023 as Director at Nutri Pharma Vaccines Private Limited.

The current boards of Rabindranath Barman's companies include Prokwana Barman (Nutri Pharma Vaccines Private Limited), Spandana Chaudhury (Nutri Pharma Vaccines Private Limited), Sumit Chaudhury (Nutri Pharma Vaccines Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available